The RSV fusion receptor: not what everyone expected it to be
- PMID: 22884716
- DOI: 10.1016/j.micinf.2012.07.015
The RSV fusion receptor: not what everyone expected it to be
Abstract
This article reviews current knowledge about respiratory syncytial virus (RSV) binding and entry into cells. The recent discovery of Nucleolin as a fusion receptor for RSV opens new avenues for developing interventions, while raising questions concerning RSV pathobiology and tropism. We also discuss characteristics of a good RSV drug target.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
